NYSE:HNGE
Hinge Health, Inc.
Hinge Health, Inc.'s revenue grew 50.6% in fiscal 2025 to $587.9M while operating margin fell to −92.9%, its lowest in 3 years. Free cash flow was $170.7M, 29.0% of revenue, and the diluted share count rose 302.5%.Summary generated from Hinge Health, Inc.'s SEC filings. Latest annual report filed Mar 3, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$587.9M
Revenue growth+50.6%
Revenue, 5-yr CAGRn/a
Gross margin79.6%
Operating margin−92.9%
Net margin−89.9%
ROICn/a
Return on equityn/a
Debt / equityn/a
Free cash flow$170.7M
FCF margin29.0%
Share count change+302.5%
Financials
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 293 | 390 | 588 |
| Operating income | −131 | −32 | −546 |
| Net income | −108 | −12 | −528 |
| Free cash flow | −66 | 48 | 171 |
Recent filings
- 4Insider transaction report
Oct 7, 2026 - 4Insider transaction report
Oct 6, 2026 - 8-KEntry into a material agreement
Aug 21, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KResults of operations and financial condition
Aug 4, 2026 - 8-KRegulation FD disclosure
Jun 9, 2026 - 8-KResults of a shareholder vote
Jun 4, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 7, 2026